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Obesity and type-2 diabetes arise from the complex inter-
play of both genetic and environmental factors. In the
past several years, we have seen considerable progress in
the use of genomics and metabolomics in investigating
the role of diet and nutrition in the etiology of obesity
and diabetes. Recent work suggests that the adverse effect
of several obesity loci especially FTO may be modified by
dietary factors. In a recent study (Qi et al. NEJM 2012),
we found a significant interaction between consumption
of Sugar-Sweetened Beverages (SSBs) and genetic var-
iants related to Body Mass Index (BMI) in three cohort
studies. A genetic-predisposition score was calculated on
the basis of 32 BMI-associated loci. We found that the
genetic association with BMI was more pronounced
among participants with higher intake of SSBs than
among those with lower intake. In the combined cohorts,
the increases in BMI per increment of 10 risk alleles were
1.00 unit for an intake of < 1 serving/month, 1.12 for 1-4
servings/month, 1.38 for 2-6 servings/week, and 1.78 for
≥ 1 servings/day (P<0.001 for interaction). This analysis
suggests that the genetic association with adiposity is
amplified by greater intakes of SSBs. In the area of nutri-
tion and metabolomics, several recent epidemiological
studies have found that plasma concentrations of meta-
bolites especially Branched-Chain Amino Acids (BCAAs)
are associated with increased risk of type-2 diabetes.
Other novel metabolite classes have also been linked to
diabetes, such as short- and medium-chain acylcarnitines,
the specific lipid classes of sphingomyelins (SMs), lyso-
phosphatidylcholines, phosphatidylcholines (PCs), and
lysophosphatidylethanolamines. Metabolomics has also
been used to characterize the complex human metabolic
effects of specific foods, nutrients, and dietary patterns in
both intervention and epidemiological studies. Our
preliminary analysis found that urinary levels of gut flora
metabolites derived from dietary intakes of polyphenols
were significantly associated with risk of diabetes.
In summary, both nutrigenomics and metabolomics stu-
dies have provided new insights to the etiology of obesity
and diabetes and individual differences in response to diet.
Continued technological advances in sensitive high-
throughput methods and enhanced bioinformatics and
analytical tools in combination with carefully conducted
population-based studies will enable more widespread use
of these technologies in nutrition and metabolic disease
research, which will eventually help to achieve the goal of
personalized nutrition for prevention and treatment of
chronic diseases.
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